我要投票 罗浮山宫炎平在女性洗液行业中的票数:622
· 外 推 电 报 ·
2026-01-08 12:17:07 星期四

【罗浮山宫炎平是哪个国家的品牌?】

罗浮山宫炎平是什么牌子?「罗浮山宫炎平」是 广东罗浮山国药股份有限公司 旗下著名品牌。该品牌发源于广东省惠州市,由创始人王 * 良在1970年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力罗浮山宫炎平品牌出海!将品牌入驻外推网,定制罗浮山宫炎平品牌推广信息,可以显著提高罗浮山宫炎平产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

广东罗浮山国药股份有限公司,座落在广东罗浮山脚下,其前身——罗浮山药业始建于1970年,至今已有四十年发展史。公司投资上亿元按GMP标准建成了产、销一体的“罗浮山药业城”,占地面积10万多平方米、建筑面积8万平方米,至今已成为拥有员工近4000人、年纳税额超四千万元的大中型企业,是目前惠州市规模较大的制药企业,也是广东省内产能较大、剂型较齐全的中成药制剂企业之一。公司位于穗深经济走廊中心,旺盛的珠三角地域,毗邻港澳,交通四通八达,环境优雅。

罗浮山国药追求“以质量为本,科技创新”的经营理念,以继承和发扬具有1600多年历史的罗浮山中医药文化为已任,以造福百姓健康为宗旨,从事中西药品的开发、生产、销售以及中药材种植、生产加工和经营。四十年来,罗浮山国药不断挖掘和继承古代医药精华,利用当地丰富的中草药资源,系列颇具特色的品种、中药保护品种畅销国内外。公司现拥有的十一个剂型12条生产线全部通过国家GMP认证。年生产能力达片剂130亿片、颗粒剂3000吨、硬胶囊3亿粒、小容量注射剂2亿支、茶剂800万袋、搽剂8000万瓶、滴丸3亿粒、软胶囊2亿粒、栓剂5000万粒;提取车间年加工中药材可达2万吨,是广东省规模较大的中药提取车间之一。企业销售额每年以20-30%的幅度稳步增长。

朝气蓬勃的罗浮山国药已逐步发展壮大成为一个集科研、生产、销售和药材种植于一体的现代化高科技制药企业。随着企业不断发展壮大,坚信罗浮山国药将走在国内同行业的前列,屹立于中华药业之林。


英文翻译:Guangdong Luofushan Guoyao Co., Ltd. is located at the foot of Guangdong Luofushan. Its predecessor, Luofushan pharmaceutical industry, was founded in 1970 and has a history of 40 years. The company has invested more than 100 million yuan to build a "Luofushan pharmaceutical city" integrating production and marketing according to GMP standards, covering an area of more than 100000 square meters and a building area of 80000 square meters. So far, it has become a large and medium-sized enterprise with nearly 4000 employees and an annual tax payment of more than 40 million yuan. It is a large-scale pharmaceutical enterprise in Huizhou at present, and a Chinese patent medicine preparation with large production capacity and complete dosage forms in Guangdong Province One of the enterprises. The company is located in the center of suishen economic corridor, the exuberant Pearl River Delta region, adjacent to Hong Kong and Macao, with convenient transportation and elegant environment. Luofushan national medicine pursues the business philosophy of "quality-oriented, scientific and technological innovation", inherits and develops the culture of Luofushan Chinese medicine with a history of more than 1600 years, and aims to benefit the people's health. It is engaged in the development, production and sales of Chinese and Western medicine as well as the cultivation, production, processing and management of Chinese medicine. Over the past forty years, Luo Fu Shan has continuously excavated and inherited the essence of ancient medicine, and made use of the rich resources of Chinese herbal medicine, and a series of distinctive varieties and traditional Chinese medicine protection varieties have been sold well both at home and abroad. The company now has 11 dosage forms and 12 production lines, all of which have passed the national GMP certification. With an annual production capacity of 13 billion tablets, 3000 tons of granules, 300 million hard capsules, 200 million small volume injections, 8 million tea bags, 80 million bottles of liniments, 300 million drop pills, 200 million soft capsules and 50 million suppositories, the extraction workshop can process 20000 tons of traditional Chinese medicine annually, which is one of the large-scale TCM extraction workshops in Guangdong Province. The sales volume of the enterprise increases steadily by 20-30% every year. The vigorous Luofushan national medicine has gradually developed into a modern high-tech pharmaceutical enterprise integrating scientific research, production, sales and medicine planting. With the continuous development and growth of the enterprise, we firmly believe that Luofushan Guoyao will be in the forefront of the same industry in China and stand in the forest of Chinese pharmaceutical industry.

本文链接: https://www.waitui.com/brand/08d919ee4.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

阿里云推出面向AI硬件的多模态交互开发套件

1月8日,阿里云发布多模态交互开发套件,该套件集成了千问、万相、百聆三款通义基础大模型,并预置十多款生活休闲、工作效率等领域的Agent和MCP工具,不仅能听、会看,还能思考并且与物理世界交互,可应用于AI眼镜、学习机、陪伴玩具、智能机器人等硬件设备。(证券时报)

18分钟前

A股三大指数午间休盘涨跌不一,航天军工板块领涨

36氪获悉,A股三大指数午间休盘涨跌不一,沪指涨0.09%,深成指跌0.2%,创业板指跌0.52%;教育、航天军工、发电设备板块领涨,百邦科技涨超16%,航天南湖涨超14%,泰胜风能涨超13%;券商、保险、工程机械板块走弱,华安证券跌超5%,中国平安跌超2%,中联重科跌超1%。

18分钟前

SHEIN:2025年全年开展培训近600场,覆盖供应商近3.7万次

36氪获悉,2025年,SHEIN在深入推进技术创新和精益化建设的同时,还持续投资于人。据了解,SHEIN全年开展培训近600场,覆盖供应商近3.7万次,关爱供应商员工的“聚星光”与“儿童之家”等公益项目均有序进行。

18分钟前

摩根士丹利:全球基金12月增持中国股票,受被动型流入支撑

36氪获悉,摩根士丹利称,上月中国股票继续吸引外资流入,主要受被动型基金流入支撑,而主动型基金仍在卖出,但卖出速度有所放缓。摩根士丹利分析师在报告中写道,12月份外资被动型基金流入H股和A股的规模加速至44亿美元,而主动型基金流出规模放缓至9亿美元,使得净流入达到35亿美元。这与11月份23亿美元的净流入相比有所上升。报告称,2025年外资净流入总额为140亿美元,而2024年为净流出170亿美元。(财联社)

18分钟前

未岚大陆CES 2026发布五大新品,首次系统化提出“Navimow标准”

36氪获悉,CES 2026期间,智能割草机器人品牌未岚大陆发布五大新品,包括面向大面积全地形庭院、主打极致性能的X4旗舰系列;搭载三重融合定位技术、专为复杂庭院设计的H2系列;针对中小面积、全驱不伤草的i2 AWD和兼顾精准导航与轻松上手的i2 LiDAR;以及面向商业场景的Terranox系列。同时,未岚大陆首次系统化提出“Navimow标准”,全系产品支持“免部署、自动建图”(Drop and Mow)。

18分钟前

本页详细列出关于罗浮山宫炎平的品牌信息,含品牌所属公司介绍,罗浮山宫炎平所处行业的品牌地位及优势。
咨询